Atara Biotherapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Atara Biotherapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2013 to Q3 2024.
  • Atara Biotherapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $3.36M, a 46.6% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.36M -$2.93M -46.6% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $3.61M -$2.97M -45.1% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $3.87M -$3.04M -44% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.84M -$2.17M -31% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $6.29M -$877K -12.2% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $6.58M -$652K -9.02% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $6.91M +$4.69M +211% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $7.02M +$4.65M +196% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $7.17M +$6.5M +970% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $7.23M +$6.54M +949% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $2.22M +$1.49M +205% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.37M +$1.54M +186% Dec 31, 2021 10-K 2023-02-08
Q3 2021 $670K -$207K -23.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $689K -$327K -32.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $729K -$268K -26.9% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $827K +$260K +45.9% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $877K +$611K +230% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.02M +$697K +218% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $997K +$461K +86% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $567K -$7K -1.22% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $266K -$219K -45.2% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $319K -$43K -11.9% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $536K +$436K +436% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $574K +$314K +121% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $485K +$385K +385% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $362K +$186K +106% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $100K -$720K -87.8% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $260K +$158K +155% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $100K -$2K -1.96% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $176K +$75K +74.3% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $820K +$731K +821% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $102K -$6K -5.56% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $102K +$4K +4.08% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $101K -$325K -76.3% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $89K +$10K +12.7% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $108K +$60K +125% Dec 31, 2015 10-K 2017-03-09
Q3 2015 $98K -$1.99M -95.3% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $426K Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $79K Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $48K +$36K +300% Dec 31, 2014 10-K 2016-03-04
Q3 2014 $2.08M Sep 30, 2014 10-Q 2014-11-12
Q4 2013 $12K Dec 31, 2013 10-K 2015-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.